Abstract:A copper‐coordinated nanoassembly (named Cu‐GM) is constructed that integrates a lactate dehydrogenase inhibitor, galloflavin (GF), with an immune checkpoint inhibitor, myricetin (MY), to boost cancer cuproptosis‐immunotherapy. It is the first time that explores the synergistic effect of glycolysis metabolism, cuproptosis, and immunotherapy, which has remarkable anti‐tumor effects in vivo and encourages further exploration of reasonable multi‐mode treatment methods.A copper‐coordinated nanoassembly (designated as Cu‐GM) is constructed that integrates a lactate dehydrogenase inhibitor, galloflavin (GF), with an immune checkpoint inhibitor, myricetin (MY), to boost cancer cuproptosis‐immunotherapy. The work innovatively explored the mutually reinforcing and complementary interactions among anaerobic glycolysis, cuproptosis, and immunotherapy, and for the first time to integrate these elements into a single carrier‐free nanoplatform with tumor‐responsive properties for synergistic cancer treatment. Interference with glycolysis metabolism not only promotes the efficient sensitization of cuproptosis, but also amplifies cytotoxic T cell functions and proliferations, thus contributing to relieve immunosuppressive tumor microenvironment. However, the synergistic mechanism and the design of multicomponent nanoformulations involving these three pathways have not yet been explored. a copper‐coordinated nanoassembly (designated as Cu‐GM) is reported here that integrates a lactate dehydrogenase inhibitor, galloflavin (GF), with an immune checkpoint inhibitor, myricetin (MY), to boost cancer cuproptosis‐immunotherapy. These results suggest that Cu‐GM can be activated by the endogenous overexpressed glutathione to release Cu+, leading to the abnormal aggregation of lipoylated proteins and iron‐sulfur cluster proteins loss, which triggers proteotoxic stress and cell cuproptosis. Meanwhile, the released GF not only inhibits the glycolysis to amplify cuproptosis efficacy but also achieves effective lactate depletion, thus alleviating immunosuppressive effects of lactate. Notably, the killed tumor cells can induce immunogenic cell death to evoke the anti‐tumor immunity, which further augmented by the MY‐mediated immune checkpoint blockade. Taken together, the first anticancer synergy of glycolysis metabolism, cuproptosis, and immunotherapy is presented, showcasing remarkable in vivo antitumor effects and encouraging further exploration of a rational multimodal treatment approach.

Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy

Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.

Glycolysis-non-canonical Glutamine Dual-Metabolism Regulation Nanodrug Enhanced the Phototherapy Effect for Pancreatic Ductal Adenocarcinoma Treatment.

4T1 Cell Membrane-Derived Biodegradable Nanosystem for Comprehensive Interruption of Cancer Cell Metabolism

Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy

Dual Inhibition of Glucose Uptake and Energy Supply Synergistically Restrains the Growth and Metastasis of Breast Cancer

A Smart Nanomedicine Unleashes a Dual Assault of Glucose Starvation and Cuproptosis to Supercharge Αpd-L1 Therapy.

Tumor Metabolism Destruction Via Metformin-Based Glycolysis Inhibition and Glucose Oxidase-Mediated Glucose Deprivation for Enhanced Cancer Therapy

Dual Starvations Induce Pyroptosis for Orthotopic Pancreatic Cancer Therapy through Simultaneous Deprivation of Glucose and Glutamine

Advanced Cancer Starvation Therapy by Simultaneous Deprivation of Lactate and Glucose Using a MOF Nanoplatform

Nanodrug Simultaneously Regulates Stromal Extracellular Matrix and Glucose Metabolism for Effective Immunotherapy Against Orthotopic Pancreatic Cancer

A Potent Nano-Strategy for Dual Energy Deprivation to Inhibit Pancreatic Cancer Progression

Nanoparticle-Mediated Inhibition of Mitochondrial Glutaminolysis to Amplify Oxidative Stress for Combination Cancer Therapy

Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer by inhibition of glutamine metabolism

Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer

A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer

Glucose-responsive Mesoporous Silica Nanoparticles to Generation of Hydrogen Peroxide for Synergistic Cancer Starvation and Chemistry Therapy

Regulating Glucose Metabolism Using Nanomedicines for Cancer Therapy.

Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy

Glutathione Induced In Situ Activation of Dual‐Locked Cuproptosis Nanoamplifier with Glycolysis Metabolism Inhibition to Boost Cancer Immunotherapy

Combination of Sirna-Directed Kras Oncogene Silencing and Arsenic-Induced Apoptosis Using A Nanomedicine Strategy for the Effective Treatment of Pancreatic Cancer